✦ LIBER ✦

Neoadjuvant tamoxifen and aromatase inhibitors: comparisons and clinical outcomes

✍ Scribed by J.M. Dixon; J. Jackson; L. Renshaw; W.R. Miller

Book ID: 117668644
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 61 KB
Volume: 86
Category: Article
ISSN: 0960-0760
DOI: 10.1016/s0960-0760(03)00370-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant comparisons of aromatase inh

Neoadjuvant comparisons of aromatase inhibitors and tamoxifen: pretreatment determinants of response and on-treatment effect

✍ Matthew J Ellis; Eric Rosen; Holly Dressman; Jeffery Marks 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Comparing aromatase inhibitors and tamox

Comparing aromatase inhibitors and tamoxifen as neoadjuvant therapy for breast cancer

✍ Fauzia Rana; Shalin Shah 📂 Article 📅 2008 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 77 KB

Pharmacogenomics of tamoxifen and aromat

Pharmacogenomics of tamoxifen and aromatase inhibitors

✍ James N. Ingle 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

In selection of therapy for women with breast cancer, the focus has been almost exclusively on the characteristics of the tumor, eg, estrogen receptor (ER) and HER-2. Until recently, essentially no attention has been paid to the host and her genetic makeup as it relates to the metabolism of differen

Biological and clinical effects of aroma

Biological and clinical effects of aromatase inhibitors in neoadjuvant therapy

✍ W.R Miller; J.M Dixon; D.A Cameron; T.J Anderson 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 299 KB

Bone safety of aromatase inhibitors vers

Bone safety of aromatase inhibitors versus tamoxifen

✍ P.E. LØNNING 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Aromatase inhibitors versus tamoxifen fo

Aromatase inhibitors versus tamoxifen for management of postmenopausal breast cancer in the advanced disease and neoadjuvant settings

✍ James N Ingle; Vera J Suman 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 91 KB